Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Researchers discovered exendin-4, a peptide structurally similar to human GLP-1 but far more resistant to enzymatic breakdown
SynaPep BPC-157 is an advanced oral peptide therapy designed to support tissue repair, calm persistent inflammation, and promote more efficient recovery
There is currently no established treatment for MAFLD and MASH other than interventions that encourage lifestyle changes and the use of medicines to control or treat metabolic disorders (95, 96)
2 Kidney Disease Risk Reduction In addition, the FDA has approved semaglutide (Ozempic) to slow the progression of kidney disease and reduce the risk of kidney failure, making it the most widely indicated GLP-1 drug
US$ 24.13
US$ 25.88
US$ 22.31
